Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic.
Aged
COVID-19
/ epidemiology
Critical Pathways
/ organization & administration
Cross Infection
/ prevention & control
Emergency Treatment
Female
Humans
Male
Middle Aged
SARS-CoV-2
Safety Management
/ organization & administration
Surgery Department, Hospital
/ organization & administration
Surgical Procedures, Operative
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
pubmed:
22
10
2020
medline:
15
12
2020
entrez:
21
10
2020
Statut:
ppublish
Résumé
The outcomes of patients treated on the COVID-minimal pathway were evaluated during a period of surging COVID-19 hospital admissions, to determine the safety of continuing to perform urgent operations during the pandemic. Crucial treatments were delayed for many patients during the COVID-19 pandemic, over concerns for hospital-acquired COVID-19 infections. To protect cancer patients whose survival depended on timely surgery, a "COVID-minimal pathway" was created. Patients who underwent a surgical procedure on the pathway between April and May 2020 were evaluated. The "COVID-minimal surgical pathway" consisted of: (A) evolving best-practices in COVID-19 transmission-reduction, (B) screening patients and staff, (C) preoperative COVID-19 patient testing, (D) isolating pathway patients from COVID-19 patients. Patient status through 2 weeks from discharge was determined as a reflection of hospital-acquired COVID-19 infections. After implementation, pathway screening processes excluded 7 COVID-19-positive people from interacting with pathway (4 staff and 3 patients). Overall, 122 patients underwent 125 procedures on pathway, yielding 83 admissions (42 outpatient procedures). The median age was 64 (56-79) and 57% of patients were female. The most common surgical indications were cancer affecting the uterus, genitourinary tract, colon, lung or head and neck. The median length of admission was 3 days (1-6). Repeat COVID-19 testing performed on 27 patients (all negative), including 9 patients evaluated in an emergency room and 8 readmitted patients. In the postoperative period, no patient developed a COVID-19 infection. A COVID-minimal pathway comprised of physical space modifications and operational changes may allow urgent cancer treatment to safely continue during the COVID-19 pandemic, even during the surge-phase.
Sections du résumé
OBJECTIVE
The outcomes of patients treated on the COVID-minimal pathway were evaluated during a period of surging COVID-19 hospital admissions, to determine the safety of continuing to perform urgent operations during the pandemic.
SUMMARY OF BACKGROUND DATA
Crucial treatments were delayed for many patients during the COVID-19 pandemic, over concerns for hospital-acquired COVID-19 infections. To protect cancer patients whose survival depended on timely surgery, a "COVID-minimal pathway" was created.
METHODS
Patients who underwent a surgical procedure on the pathway between April and May 2020 were evaluated. The "COVID-minimal surgical pathway" consisted of: (A) evolving best-practices in COVID-19 transmission-reduction, (B) screening patients and staff, (C) preoperative COVID-19 patient testing, (D) isolating pathway patients from COVID-19 patients. Patient status through 2 weeks from discharge was determined as a reflection of hospital-acquired COVID-19 infections.
RESULTS
After implementation, pathway screening processes excluded 7 COVID-19-positive people from interacting with pathway (4 staff and 3 patients). Overall, 122 patients underwent 125 procedures on pathway, yielding 83 admissions (42 outpatient procedures). The median age was 64 (56-79) and 57% of patients were female. The most common surgical indications were cancer affecting the uterus, genitourinary tract, colon, lung or head and neck. The median length of admission was 3 days (1-6). Repeat COVID-19 testing performed on 27 patients (all negative), including 9 patients evaluated in an emergency room and 8 readmitted patients. In the postoperative period, no patient developed a COVID-19 infection.
CONCLUSIONS
A COVID-minimal pathway comprised of physical space modifications and operational changes may allow urgent cancer treatment to safely continue during the COVID-19 pandemic, even during the surge-phase.
Identifiants
pubmed: 33086321
doi: 10.1097/SLA.0000000000004455
pmc: PMC7668334
pii: 00000658-202012000-00056
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e316-e320Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Références
Grotenhuis BA, van Hagen P, Wijnhoven BP, et al. Delay in diagnostic workup and treatment of esophageal cancer. J Gastrointest Surg 2010; 14:476–483.
Samson P, Crabtree TD, Robinson CG, et al. Defining the ideal time interval between planned induction therapy and surgery for stage IIIA non-small cell lung cancer. Ann Thorac Surg 2017; 103:1070–1075.
Grass F, Behm KT, Duchalais E, et al. Impact of delay to surgery on survival in stage I-III colon cancer. Eur J Surg Oncol 2020; 46:455–461.
ACS Guidelines for Triage and Management of Elective Cancer Surgery Cases During the Acute and Recovery Phases of Coronavirus Disease 2019 (COVID-19) Pandemic May 7, 2020. 2020. Available at: https://www.facs.org/-/media/files/covid19/acs_triage_and_management_elective_cancer_surgery_during_acute_and_recovery_phases.ashx. Accessed June 3, 2020.
Thoracic Surgery Outcomes Research Network, Inc, Antonoff M, Backhus L, Boffa DJ, et al. COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network. Ann Thorac Surg. 2020;110:692–696.
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382:1708–1720.
Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020; 395:1907–1918.
Lei S, Jiang F, Su W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine 2020; 21:100331doi: 10.1016/j.eclinm.2020.100331.
doi: 10.1016/j.eclinm.2020.100331
Aminian A, Safari S, Razeghian-Jahromi A, Ghorbani M, Delaney CP. COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period. Ann Surg 2020; 272:e27–e9.
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21:335–337.
Collaborative CO. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020; 396:27–38.
Boffa DJ, Judson BL, Billingsley KG, et al. Pandemic recovery using a COVID-minimal cancer surgery pathway. Ann Thorac Surg 2020; 110:718–724.
Qin J, You C, Lin Q, Hu T, Yu S, Zhou XH. Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study. medRxiv 2020.
Li YK, Peng S, Li LQ, et al. Clinical and transmission characteristics of Covid-19 - a retrospective study of 25 cases from a single thoracic surgery department. Curr Med Sci 2020; 40:295–300.
Luong-Nguyen M, Hermand H, Abdalla S, et al. Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery. J Visc Surg 2020.
McDermott A, O’Kelly J, de Barra E, et al. Perioperative outcomes of urological surgery in patients with SARS-CoV-2 infection. Eur Urol 2020; 78:118–120.
Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020; 395:1919–1926.
Lin EE, Blumberg TJ, Adler AC, et al. Incidence of COVID-19 in pediatric surgical patients among 3 US children's hospitals. JAMA Surg 2020.
Worldometer. COVID-19 Coronavirus Pandemic June 2, 2020, 2020. 2020. Available at: https://www.worldometers.info/coronavirus/. Accessed June 3, 2020.
Prevention CfDCa. How Covid-19 Spreads 4/13/2020, 2020. Accessed April, 23, 2020.
Organization WH. Basic Protective Measures Against the New Coronavirus 3/31/2020, 2020. Accessed April, 23, 2020.
Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med 2020; 173:262–267.
Al-Shamsi HO, Coomes EA, Alrawi S. Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates. JAMA Oncol 2020.